Colgate-Palmolive Company $CL Shares Sold by Cidel Asset Management Inc.

Key Points

• Cidel Asset Management cut its Colgate-Palmolive stake by 38% in the third quarter, selling 86,314 shares and retaining 140,740 shares valued at approximately $12.0 million. Institutional investors and hedge funds collectively own 80.41% of the company.
• Colgate-Palmolive reported a quarterly earnings beat, with adjusted EPS of $0.97 and revenue of $5.37 billion, up 4.6% year over year. Management improved its base-business profitability outlook, although it narrowed its full-year sales-growth forecast amid weak U.S. demand and rising input costs.
• Analysts maintain a favorable view, with a consensus rating of “Moderate Buy” and an average price target of $98.56. The company also declared a quarterly dividend of $0.53 per share, representing a 2.2% annualized yield.

Cidel Asset Management Inc. trimmed its holdings in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 38.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 140,740 shares of the company's stock after selling 86,314 shares during the period. Cidel Asset Management Inc.'s holdings in Colgate-Palmolive were worth $12,008,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the business. State Street Corp boosted its stake in shares of Colgate-Palmolive by 97.4% in the second quarter. State Street Corp now owns 94,195,992 shares of the company's stock valued at $8,635,889,000 after buying an additional 46,476,510 shares in the last quarter. Bank of New York Mellon Corp raised its position in Colgate-Palmolive by 8.1% in the second quarter. Bank of New York Mellon Corp now owns 13,532,417 shares of the company's stock worth $1,240,652,000 after acquiring an additional 1,010,872 shares in the last quarter. First Eagle Investment Management LLC raised its position in Colgate-Palmolive by 1.1% in the second quarter. First Eagle Investment Management LLC now owns 8,205,699 shares of the company's stock worth $752,298,000 after acquiring an additional 88,917 shares in the last quarter. Bank of America Corp DE lifted its holdings in Colgate-Palmolive by 17.4% in the first quarter. Bank of America Corp DE now owns 6,637,597 shares of the company's stock valued at $565,722,000 after acquiring an additional 986,063 shares during the period. Finally, Amundi lifted its holdings in Colgate-Palmolive by 19.9% in the second quarter. Amundi now owns 6,218,257 shares of the company's stock valued at $570,090,000 after acquiring an additional 1,033,918 shares during the period. 80.41% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Colgate-Palmolive news, Director John T. Cahill sold 4,170 shares of Colgate-Palmolive stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $93.37, for a total transaction of $389,352.90. Following the completion of the transaction, the director owned 28,373 shares in the company, valued at approximately $2,649,187.01. The trade was a 12.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO Panagiotis Tsourapas sold 10,000 shares of Colgate-Palmolive stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $92.05, for a total transaction of $920,500.00. Following the transaction, the chief operating officer owned 64,901 shares of the company's stock, valued at approximately $5,974,137.05. The trade was a 13.35% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 175,191 shares of company stock worth $16,110,903 in the last three months. Corporate insiders own 0.43% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages have commented on CL. Deutsche Bank Aktiengesellschaft restated a "buy" rating and set a $101.00 target price (up from $99.00) on shares of Colgate-Palmolive in a research report on Monday, August 3rd. TD Cowen increased their price target on shares of Colgate-Palmolive from $85.00 to $90.00 and gave the company a "hold" rating in a report on Monday, August 3rd. Weiss Ratings downgraded shares of Colgate-Palmolive from a "buy (b-)" rating to a "hold (c+)" rating in a report on Friday, October 2nd. Citigroup raised their price objective on shares of Colgate-Palmolive from $105.00 to $110.00 and gave the company a "buy" rating in a research note on Tuesday, July 14th. Finally, Evercore boosted their price objective on shares of Colgate-Palmolive from $100.00 to $101.00 and gave the stock an "outperform" rating in a report on Thursday, October 8th. Thirteen analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $98.56.

Trending Headlines about Colgate-Palmolive

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Third-quarter adjusted earnings were $0.97 per share, above the roughly $0.92–$0.93 analyst consensus and up from $0.91 a year earlier. Revenue increased 4.6% year over year to $5.37 billion, also exceeding expectations. Colgate-Palmolive Surpasses Q3 Earnings and Revenue Estimates
• Positive Sentiment: Organic sales growth, pricing, higher volumes and productivity initiatives supported the quarterly beat. Management raised its 2026 base-business EPS and gross-margin outlook, signaling better profitability despite cost pressures. Colgate Q3 Earnings Beat Estimates on Organic Sales and Pricing Gains
• Positive Sentiment: The company maintained its fiscal 2026 EPS outlook while improving its base-business profitability forecast. The stronger guidance likely explains the favorable investor reaction and elevated trading activity. Colgate-Palmolive Raises FY26 Base-Business EPS View
• Neutral Sentiment: Management narrowed its full-year sales-growth outlook, suggesting that pricing and productivity—not broad-based demand—remain important drivers of performance. Colgate-Palmolive Raises Profit Outlook Despite Weak US Demand
• Negative Sentiment: Weak U.S. demand and rising input costs remain risks. The earnings beat was strong, but investors may question how sustainable margin gains will be if consumer demand softens or cost inflation accelerates. Colgate-Palmolive Q3 Analysis

Colgate-Palmolive Stock Performance

NYSE CL opened at $95.35 on Friday. The business has a 50 day moving average price of $89.54 and a 200 day moving average price of $89.65. The company has a market capitalization of $76.01 billion, a P/E ratio of 37.39, a PEG ratio of 4.61 and a beta of 0.33. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $99.33. The company has a debt-to-equity ratio of 13.82, a current ratio of 1.03 and a quick ratio of 0.67.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its earnings results on Friday, October 30th. The company reported $0.97 EPS for the quarter, topping analysts' consensus estimates of $0.93 by $0.04. The company had revenue of $5.37 billion for the quarter, compared to the consensus estimate of $5.34 billion. Colgate-Palmolive had a return on equity of 464.63% and a net margin of 9.68%. Colgate-Palmolive's quarterly revenue was up 4.6% compared to the same quarter last year. During the same period in the previous year, the business earned $0.91 earnings per share. Sell-side analysts expect that Colgate-Palmolive Company will post 3.89 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Tuesday, October 20th will be paid a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Tuesday, October 20th. Colgate-Palmolive's payout ratio is 84.13%.

About Colgate-Palmolive

Colgate-Palmolive Company NYSE: CL is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwash, liquid hand soap, body wash, deodorants, household cleaning products and pet food and treats.

The company markets well-known brands such as Colgate, Palmolive, elmex, meridol, Softsoap, Irish Spring, Ajax, Protex and Hill's Science Diet. Colgate-Palmolive also provides veterinary and nutritional products through Hill's Pet Nutrition, which serves pet owners and animal health professionals.

Founded in 1806 by William Colgate, the company developed from a soap and candle business into a diversified consumer goods manufacturer.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.